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Demonstration of a Posterior Atrial Input to the Atrioventricular
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CHARLIE YOUNG, MD, FACC, MICHAEL R. LAUER, MD, PHD, L. BING LIEM, DO,
HINGSON CHUN, MD, RUEY J. SUNG, MD, FACC
San Jose and Stanford, California
Objectives. This study sought to demonstrate electrophysiologic
evidence for the existence of different anatomic atrial input sites of
fast and slow conduction pathways in patients with dual atrioven-
tricular (AV) node physiology.
Background. Although a separate posterior exit site exists for a
retrograde slow AV node pathway, it remains unresolved whether
a separate atrial input site into the AV node actually exists in
patients with dual anterograde AV node pathway physiology.
Methods. In 10 patients with dual AV node pathway physiology,
atrial pacing at three chosen drive cycle lengths (DCL1, DCL2
and DCL3) was performed at an anterior site (A) just above the
His bundle recording site and at a posterior atrial site (P) just
below the coronary sinus ostium. DCL3 was chosen as the one
cycle length that resulted in a long AH interval consistent with
slow pathway conduction. The stimulus to His bundle conduction
times (SH) at both sites (SHP and SHA, respectively) and their
differences (DSH 5 SHP 2 SHA) at each of the three drive cycle
lengths were analyzed.
Results. The mean 6 SD DSH values for DCL1 and DCL2
measured 9 6 16 and 8 6 18 ms, respectively, and the mean DSH
value at DCL3 measured 234 6 24 ms, which was significantly
different from the mean DSH values at DCL1 and DCL2 (both p <
0.05).
Conclusions. The significant change in the DSH (SHP 2 SHA)
value during slow pathway conduction could be accounted for by
a corresponding shift of anterograde input from an anterior to a
posterior entry site to the AV node. These findings support the
notion that a separate anterograde entry site of the slow pathway
does exist in patients with dual AV node pathway physiology.
(J Am Coll Cardiol 1998;31:1615–21)
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Atrioventricular (AV) node modification by selective radiofre-
quency energy catheter ablation of the slow conducting AV
node pathway is an effective curative treatment for patients
with AV node reentrant tachycardia (1–4). In 1981, Sung et al.
(5) showed that the retrograde exit site of the slow pathway
was located near the coronary sinus ostium, posteriorly and
inferiorly to that of the fast pathway. Many investigators
(1–3,6–9) have subsequently shown that catheter ablation
lesions placed along the tricuspid valve annulus in the posterior
aspect of the interatrial septum near the coronary sinus ostium
can selectively eliminate or modify anterograde slow AV node
conduction without affecting anterograde fast AV node con-
duction. These findings confirm that the slow conducting
pathway is anatomically distinct from the fast pathway. How-
ever, it remains unresolved whether a separate anterograde
atrial input into the AV node actually exists in humans.
We hypothesized that the fast and slow pathways may
indeed have anatomically different atrial entry sites, with the
input to the slow pathway located more posterior and inferior
than the input to the fast pathway. In the present study, we
designed a unique atrial pacing protocol with differential site
pacing to electrophysiologically demonstrate the presence of
separate atrial entry sites of fast and slow pathways.
Method
Patients. Twenty consecutive patients undergoing radio-
frequency catheter ablation for AV node reentrant tachycardia
were evaluated. Standard intracardiac electrode catheters were
positioned in the coronary sinus (CS), high right atrium, right
ventricular apex and the His bundle region. Intracardiac and
surface electrocardiographic leads I, aVF and V1 were contin-
uously recorded and stored for analysis (ART, Inc.). Interval
measurements were performed using the computerized cali-
pers at 100-mm/s sweep speed. The baseline electrophysiologic
study was performed with atrial and ventricular stimulation,
respectively, at twice diastolic threshold and 2.0 ms in duration
through a programmable stimulator (model DTU-125, Bloom
Associates, Ltd.)
Study Protocol. Ten of the 20 patients with inducible AV
node reentrant tachycardia were selected for study. All 10
patients manifested dual AV node physiology with discontin-
uous AV node conduction curves (A1A2, A2H2; A1A2, H1H2)
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(i.e., an increment of at least 50 ms in the AH interval after a
shift from fast to slow pathway conduction). In addition, during
burst atrial pacing, a greater than 50 ms increment in the A1H1
interval resulting from a critical 10-ms decrement in the S1S1
interval was also demonstrated. Furthermore, patients were
specifically selected on the basis of their ability to achieve a
stable “steady state” AV node conduction during continuous
atrial pacing at various cycle lengths. Steady state conduction
was achieved when the AH interval varied ,5 ms during at
least 10 s of atrial pacing. Patients were also excluded if the
induction of AV node reentrant tachycardia during pacing
interfered with the study or if the AV node Wenckebach
phenomenon had occurred before stable AV node conduction
was achieved. After the baseline electrophysiologic study was
completed, the high right atrial and right ventricular apex
catheters were replaced with two 4-mm large-tipped deflect-
able 7F quadripolar catheters with 2-mm interelectrode dis-
tance. These two electrode catheters were positioned to obtain
clear bipolar atrial electrograms and stable pacing thresholds
at two selected sites. One catheter was placed at the anterior
atrial septum (site A), just above the His bundle recording site,
and the other was placed at the posterior atrium (site P), just
below the CS ostium (Fig. 1). The distal pair of electrodes was
used for stimulation and the proximal pair for recording the
local electrogram. During baseline conditions, three progres-
sively shorter fixed pacing drive cycle lengths (DCLs), were
chosen for study. The DCLs were specifically chosen such that
the two longer DCLs resulted in constant short AH intervals
representative of fast pathway conduction, and the third, or
shortest DCL produced the longest constant AH interval
representing slow pathway conduction without inducing the
AV node Wenckebach phenomenon or AV node reentrant
tachycardia. The AH interval at this shortest DCL was within
the range of slow pathway conduction as defined by the A1A2
versus A2H2 curve measured during the baseline atrial extra-
stimulation study (Table 1), ensuring that the drive chosen
indeed resulted in slow pathway conduction. These preselected
DCLs (DCL1, DCL2, DCL3, e.g., 660, 530, 500 ms) were then
used to perform the three pacing trials in each patient. Pacing
from each site was performed at a 2-ms pulse width and at
twice diastolic threshold of the pacing site with the greater
threshold. All pacing studies were completed with ,3.0-V
maximal pulse amplitude. During each pacing trial, pacing was
initially begun at site A, and after achieving steady state (at
least 15 beats), the pacing site was abruptly switched to site P.
Defined measurement intervals. The conduction time from
the pacing sites (A or P) through the AV node to the His
bundle was measured as the interval from the stimulus artifact
to the His bundle potential (SH interval). SH intervals were
measured over 5 consecutive beats with ,5 ms of absolute
variation for all beats measured. During each pacing trial, the
SH conduction times recorded at site A (SHA) and site P
(SHP) were compared, and the difference in conduction time
between these two sites was calculated as DSH 5 SHP 2 SHA.
Figure 2 illustrates an example of measured data from Patient
10. The three DSH values for each of the pacing trials
performed in each patient were then compared for statistically
significant differences.
Statistical Analysis. Results are expressed as mean
value 6 SD. Statistical analysis among the three groups was
performed with the use of one-way analysis of variance, with
multiple comparisons performed with the two-tailed Student-
Newman-Keuls test. Statistical significance was accepted at the
p , 0.05 level.
Results
Electrophysiologic characteristics. The baseline electro-
physiologic data of the 10 patients are summarized in Table 1.
In addition to effective refractory periods of fast and slow
pathways, the range of AH intervals of both pathways derived
from A1A2 versus A2H2 at 600-ms drive are displayed. In all 10
patients, the longest AH interval (A2H2 at 600 ms drive) for
Abbreviations and Acronyms
A 5 anterior site
AH 5 atrio–His interval measured at the His recording
catheter
AV 5 atrioventricular
CS 5 coronary sinus
DCL 5 drive cycle length
P 5 posterior site
SHA 5 stimulus to His interval measured at site A during each
pacing study
SHP 5 stimulus to His interval measured at site P during each
pacing study
DSH 5 SHP 2 SHA-derived difference of SH values measured
at sites P and A for each drive cycle length studied
Figure 1. Fluoroscopic image (30° right anterior oblique projection)
indicating the catheter positions during the pacing studies. Sites A and
P are displayed relative to the location of the His bundle electrode
(HBE) and CS catheters.
1616 YOUNG ET AL. JACC Vol. 31, No. 7
POSTERIOR ATRIAL INPUT TO AV NODE June 1998:1615–21
fast pathway conduction was #220 ms (range 150 to 220 ms).
In contrast, the longest AH intervals for slow pathway conduc-
tion measured ranged from 320 to 450 ms. The shortest slow
pathway conduction time measured at the shift from fast to
slow pathway conduction was never ,210 ms (range 210 to
330 ms). Retrograde AV node conduction during ventricular
pacing at corresponding DCLs was always through the fast
pathway in these 10 patients. Typical slow–fast AV node
reentrant tachycardia was inducible in all patients. Selective
catheter ablation of slow pathway conduction was performed
successfully in all 10 patients by means of previously described
techniques (1–3,6–9).
Patterns of AV node conduction and measurement of
conduction time. Figure 2 shows how all SH conduction times
were measured over 5 consecutive beats with ,5 ms of
absolute variation. However, as noted in Figure 2C, after the
switch from pacing at site A with an SH of 385 ms, there was
persistence of a long SH interval of 381 ms before the
adjustment to a new and stable shorter SH of 335 ms. This
phenomenon was noted in all 10 patients during pacing at
DCL3 and was not noted to be significant in any patients at
DCL1 or DCL2.
The SH conduction times from each patient recorded from
sites A and P during pacing with each of the three cycle lengths
(DCL1 to DCL3) are displayed in Table 2. Longer SH times
were seen at successively shorter DCLs in all patients. The SH
times for DCL1 and DCL2 were both short (mean SHA 5
126 6 29 ms, SHP 5 135 6 25 ms for DCL1; mean SHA 5
146 6 26 ms, SHP 5 154 6 26 ms for DCL2) compared with
the much longer SH time measured at the DCL3 (mean SHA
5 350 6 67 ms, SHP 5 315 6 76 ms).
The DSH values (SHP 2 SHA) for all patients at each DCL
are also displayed in Table 2. The range of DSH values was
noted to be wide in each of the DCLs (220 to 25 ms, 230 to
26 ms, 280 to 5 ms for DCL1, DCL2, DCL3, respectively). The
difference in mean DSH values between DCL1 and DCL2 (9 6
16 and 8 6 18 ms) was not statistically different. However, the
mean DSH at DCL3 measured 234 6 24 ms, which was
significantly different from the mean DSH at DCL1 and DCL2
(both p , 0.05). Figure 3 shows a summary plot of the data
displayed in Table 2 and compares DSH values among all three
DCLs for each patient. Again note that DSH is similar for
DCL1 and DCL2 but is markedly different from DCL3 within
each individual patient, as well as for the mean values of the
entire group.
Discussion
AV node conduction patterns during drive trains. All
patients studied had dual AV node pathway conduction pat-
terns demonstrable at baseline by discontinuous A1A2 A2H2;
A1A2, H1H2 curves (Table 1). Evidence of a dual pathway
conduction pattern was also demonstrated during incremental
atrial pacing by a sudden increment in A1H1 (.50 ms)
associated with a critical 10-ms decrease in pacing cycle length.
A sudden increase in conduction time with AH intervals in the
slow pathway range strongly supported that slow pathway
conduction was present in these patients when the pacing cycle
length was changed from DCL2 to DCL3. Thus, AV node
conduction time measured during DCL3 pacing trial repre-
sented slow pathway conduction, whereas during DCL1 and
DCL2 pacing trials, AV node conduction was through the fast
pathway.
Changes in DSH related to differential site of pacing. In
the present study, a geometric argument is put forth such that
if a separate slow pathway input is located at the posterior
inferior aspect of the AV node region, then the conduction
time measured during slow AV node conduction from stimulus
to His bundle recording should be shorter when pacing is
performed closer to the slow pathway input posteriorly at site
P (SHP) and longer when pacing further away anteriorly at site
A (SHA). Conversely, during fast pathway conduction, because
the input to the fast pathway is now more anterior, the
measured conduction time at site P (SHP) is now longer than
Table 1. Baseline Electrophysiologic Data for 10 Patients
Pt
No.
AH
(ms)
HV
(ms)
AV BCL
(ms)
Fast Pathway Slow Pathway
VA BCL
(ms)
SVT CL
(ms)
ERP (600)
(ms)
AH Range
(ms)
ERP (600)
(ms)
AH Range
(ms)
1 83 55 400 370 83–180 260 250–450 300 370
2 90 35 450 430 90–150 ,240 210–380 450 320
3 90 45 350 460 90–190 290 270–350 350 300
4 85 35 240 450 85–175 250 240–370 280 300
5 92 55 310 300 92–220 ,220 280–320 240 420
6 75 40 400 420 75–200 280 250–330 350 320
7 95 40 450 500 95–210 290 300–400 350 340
8 80 45 350 360 80–160 240 240–410 340 350
9 100 40 380 440 100–180 300 280–390 700 320
10 79 47 450 420 79–175 320 256–452 450 360
AH Range 5 measured range of AH intervals recorded during fast or slow pathway conduction; AV BCL 5 atrioventricular (AV) node block cycle length; ERP
(600) 5 effective refractory period of the AV node of the indicated conduction pathway at a drive cycle length of 600 ms; Pt 5 patient; SVT CL 5 cycle length of the
supraventricular tachycardia; VA BCL 5 ventriculoatrial conduction block cycle length through the normal AV node pathway.
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at site A (SHA). Given this hypothesis, if the relation between
SHP and SHA is then represented by a single variable DSH
(DSH 5 SHP 2 SHA), it is therefore expected that DSH will be
different during fast compared with slow pathway conduction.
Results of the present study (Table 2, Fig. 3) showed that
DSH was not significantly different during fast pathway con-
duction at both DCL1 and DCL2 but that it was significantly
different during slow pathway conduction at DCL3. Because
conditions that may affect intranode conduction should be the
same for all three DCLs, this change in DSH during slow
pathway conduction (DCL3) is best explained by an actual
change in the atrial entry site to the slow pathway itself.
This unique pacing protocol, whereby an instantaneous
switch in pacing site was accomplished without interrupting the
continuity of the drive train, was designed to minimize the
moment to moment variability in AV node conduction time
Figure 2. Intracardiac recordings of
atrial pacing study from Patient 10 at
three DCLs are shown. Pacing was
performed at drive cycle lengths of
660 ms (DCL1) (A), 530 ms (DCL2)
(B) and 500 ms (DCL3) (C). Surface
lead I, with intracardiac channels
from the His and sites A and P, is
displayed. In each panel, the left side
of the tracing shows pacing from site
A at a given drive cycle length
(DCL1, DCL2 or DCL3). At the
label “Switch,” the pacing site was
changed instantaneously to site P
without changing the DCL. The
measured SH times (SHA or SHP)
are displayed on the His recording
channel. Note the different but con-
stant SH conduction times recorded
from both sites after the switch in the
pacing site. The SH times measured
at sites P and A are compared at
each DCL, and the difference is rep-
resented as a DSH value for that
DCL and is shown in each panel.
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resulting from variation in influences of autonomic tone during
the course of the electrophysiologic study. Thus, with other
factors affecting AV node conduction minimized, this pacing
protocol allowed for an easier method of studying the direct
effect of differential site pacing on measured conduction times
during fast and slow pathway conduction.
As was previously noted in the results section, Figure 2C
illustrates an interesting phenomenon of a persistent long SH
interval 1 beat after the switch from pacing site A to site P
during DCL3. This phenomenon may be inherent in the study
design, which requires a transition where one pacing site is
instantly switched to another. At this transition point, stimu-
lation occurs uninterrupted and in sequence from two separate
points (site A and then site P, respectively). Because there is a
latency for arrival of the first stimulus from site A to site P
when pacing is then suddenly switched to site P, a shorter local
A1A1 interval than the intended S1S1 interval results for this
transitional beat (Fig. 2C, S1S1 5 500, A1A1 5 470 at site P).
Furthermore, given that the putative entry site of the slow
pathway may be more posterior, a shorter A1A1 interval at this
Figure 2 (continued). In panel C, for
the first beat after the switch to site
P, the SH interval (381 ms) is persis-
tently long before it stabilizes to a
shorter SH interval (335 ms) after
the second beat. Also note that it is
only at this transitional beat that the
A1A1 interval is shorter than the S1S1
interval at site P (S1S1 5 500 ms;
A1A1 5 470 ms).
Table 2. Summary Data of Relative Conduction Times
Pt
No.
Drive Cycle Length 1 Drive Cycle Length 2 Drive Cycle Length 3
DCL
(ms)
SHP
(ms)
SHA
(ms)
DSH
(ms)
DCL
(ms)
SHP
(ms)
SHA
(ms)
DSH
(ms)
DCL
(ms)
SHP
(ms)
SHA
(ms)
DSH
(ms)
1 600 170 155 15 500 190 185 5 430 475 490 215
2 700 130 145 215 500 130 135 25 480 265 320 255
3 500 125 105 20 400 160 145 15 380 340 380 240
4 800 125 125 0 750 135 145 210 500 275 310 235
5 600 130 150 220 500 140 170 230 450 210 290 280
6 750 182 170 12 650 206 180 26 400 237 251 214
7 700 140 125 15 600 160 145 15 450 370 400 230
8 600 110 90 20 400 135 110 25 350 345 340 5
9 600 135 110 25 500 150 130 20 410 300 330 230
10 600 102 81 21 500 131 114 17 430 335 385 250
Mean 645 135 126 9* 530 154 146 8* 428 315 350 234†
6SD 690 625 629 616* 6109 626 626 618* 645 676 667 624†
*p 5 NS, DCL1 versus DCL2. †p , 0.05, DCL1 versus DCL3 and DCL2 versus DCL3. DCL 5 drive cycle length used during each of three pacing studies in each
patient; SHP 5 stimulus to His time recorded during pacing at site P; SHA 5 stimulus to His time recorded during pacing from site A; DSH 5 difference of SHP and
SHA (SHP 2 SHA), at drive cycle length studied.
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transitional beat will have the likely effect of prolonging the SH
interval and canceling any shortening that might be expected
from pacing at site P. This phenomenon was not observed at
DCL1 and DCL2, possibly because the effect of this different
transitional A1A1 interval on AV node conduction may not be
as noticeable at these two DCLs, which are associated with
shorter SH times. Because this phenomenon occurred only at
the transitional beat, and may be a direct result of the pacing
design, we do not consider that other mechanisms such as
variable vagal influences are needed to account for these
findings.
During slow pathway conduction (DCL3), the mean DSH
value of 234 6 24 ms (range 15 to 280) suggests that site P
is on average 34 6 24 ms closer to the slow pathway atrial entry
point than site A. During fast pathway conduction at DCL1
and DCL2, the mean DSH values (9 6 16, 8 6 18, respectively)
were positive. However, 3 of 10 patients did show negative
values (Table 2), suggesting that the fast pathway input was
actually closer to site P than site A in these patients. The
location of the putative input of the fast pathway may be
variable and even more posterior in some patients (10,11).
Therefore, in the three patients in whom DSH was a negative
value, the entry site of the fast pathway may have been located
between the pacing sites and actually closer to site P. Despite
the negative value found during fast pathway conduction, all
three patients showed significantly more negative DSH values
during slow pathway conduction, suggesting that a shift to a
more posterior input site had occurred as well. Finally, al-
though a wide range of DSH values were noted in the results,
this variability should not affect the study, which was designed
to have each patient serve as his or her own control for
comparison of fast and slow pathway conduction.
Electrophysiologic implications. Although many reports
do support separate fast and slow pathways, few reports offer
more direct evidence regarding the existence of separate atrial
inputs to the AV node in humans (3,8,12–14). Keim et al. (15)
used intraoperative ice mapping around the AV node region to
determine the critical areas of fast and slow pathway conduc-
tion during AV node reentrant tachycardia. They found that
despite being able to terminate the tachycardia by affecting
slow pathway conduction at sites peripheral to the compact AV
node posteriorly, they were unable to affect the tachycardia
within a large area located in between. On the basis of these
findings, they suggested that during typical slow–fast AV node
reentrant tachycardia, the septal wave front that has exited the
fast pathway to the atrial septum superiorly cannot enter the
slow pathway at sites near the compact node because of either
anatomic absence of connection or functional refractoriness of
these fibers. The wave front enters more distally into the slow
pathway located along the tricuspid annulus near the CS os and
propagates along the pathway into the compact AV node (15).
Satoh et al. (16) demonstrated orthodromic rather than anti-
dromic capture of the atrial myocardium adjacent to the fast
pathway exit site during entrainment of typical slow–fast AV
node reentrant tachycardia with pacing from the CS os. They
argued that this finding would support the existence of a
posterior input to the slow pathway during AV node reentrant
tachycardia. That is, only an impulse that originates near the
entry site of the slow pathway would have access to the widest
excitable gap that would allow entrainment of the tachycardia
in such a unique manner (16). Our present study, although very
different in design, provides further electrophysiologic evi-
dence for the existence of separate atrial inputs to the AV
node that are used during fast and slow AV node conduction.
Furthermore, these inputs may be anatomically fixed in loca-
tion and are accessible as separate fast and slow entry sites
used for anterograde AV node conduction during atrial pac-
ing.
Figure 3. Graphic representation of DSH de-
termined at DCL1, DCL2 and DCL3 for 10
patients. Note that DSH values measured at
DCL3 are significantly different from those
calculated at DCL 1 and DCL 2.
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Study limitations. The present study was designed to eval-
uate the patterns of AV node conduction by means of a simple
geometric argument. This argument assumes that conduction
within the AV node region is constant and that the measured
differences in the conduction times only reflect differences in
location of input sites during fast and slow pathway conduc-
tion. Differences in conduction velocity within this region that
may result from the effect of fiber orientation relative to the
wave front of impulse conduction were not considered in the
design of the study. That is, slow pathway fibers may be
oriented such that the wave front of impulse conduction is
more perpendicular to fiber orientation when pacing is per-
formed at site A than at site P. This configuration would then
result in selectively longer measured slow pathway conduction
times at site A, and in this way, SHA during DCL3 would be
consistently longer than SHP, as seen in the present study. The
present study does not exclude this alternative explanation for
the results. However, because separate retrograde fast and
slow pathway exit sites are known to exist, it would seem more
likely that separate input sites to fast and slow pathways may
also exist.
Patients in our study were selected to meet the require-
ments of the study protocol, which may have resulted in
selection for a limited cohort of patients with AV node
reentrant tachycardia. Some variability in AV node anatomy of
fast and slow pathway exit points among a small number of
patients has been described (17,18). Because our study group
was small, our findings may not apply to all patients with AV
node reentrant tachycardia, particularly those with smooth AV
node conduction curves.
Without using autonomic blockade, this study was designed
to minimize the variation in AV node conduction that may
occur during the study. Although we expect no significant
change in the data, it is not known how inclusion of autonomic
blockade would additionally affect the data.
The current study was not designed to evaluate the AV
node reentry circuit involved in the genesis of the tachycardia.
Therefore, the findings obtained with differential sites of atrial
pacing may not truly reflect the functional circuit during AV
node reentrant tachycardia and cannot be used to address the
true nature or location of the upper turnaround portion of the
AV node reentrant circuit. Finally, the study cannot answer
whether anterograde and retrograde exit sites are the same or
different because of the inherent limitations of the study
protocol.
Conclusions. We used a unique pacing protocol specifically
to overcome the problem of variable conduction in the AV
node due to moment to moment changes in autonomic tone
and were able to stabilize AV node conduction times for
differential site pacing at the AV junction. On the basis of the
results of the study, we believe that we provide evidence for the
existence of distinctly different anatomic atrial entry sites for
the fast and slow conduction pathways. During atrial pacing,
entry to the slow conduction pathway occurs at a posterior and
inferior site separate from the anterior and superior entry site
of the fast conduction pathway in patients with dual AV node
pathway physiology.
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